Charles B. Hicks

6.9k total citations
115 papers, 3.8k citations indexed

About

Charles B. Hicks is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Charles B. Hicks has authored 115 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Infectious Diseases, 65 papers in Virology and 28 papers in Epidemiology. Recurrent topics in Charles B. Hicks's work include HIV Research and Treatment (65 papers), HIV/AIDS Research and Interventions (58 papers) and HIV/AIDS drug development and treatment (56 papers). Charles B. Hicks is often cited by papers focused on HIV Research and Treatment (65 papers), HIV/AIDS Research and Interventions (58 papers) and HIV/AIDS drug development and treatment (56 papers). Charles B. Hicks collaborates with scholars based in United States, United Kingdom and France. Charles B. Hicks's co-authors include Roy M. Gulick, Joseph J. Eron, Nwora Lance Okeke, Meredith E. Clement, Walter H. Carter, Georgia D. Tomaras, Guido Ferrari, Barton F. Haynes, Robert Parks and Martin King and has published in prestigious journals such as The Lancet, JAMA and SHILAP Revista de lepidopterología.

In The Last Decade

Charles B. Hicks

111 papers receiving 3.7k citations

Peers

Countries citing papers authored by Charles B. Hicks

Since Specialization

Citations

This map shows the geographic impact of Charles B. Hicks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles B. Hicks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles B. Hicks more than expected).

Fields of papers citing papers by Charles B. Hicks

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles B. Hicks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles B. Hicks. The network helps show where Charles B. Hicks may publish in the future.

Co-authorship network of co-authors of Charles B. Hicks

This figure shows the co-authorship network connecting the top 25 collaborators of Charles B. Hicks. A scholar is included among the top collaborators of Charles B. Hicks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles B. Hicks. Charles B. Hicks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Comprehensive Literature Review of Treatment-Emergent Integrase Resistance with Dolutegravir-Based Regimens in Real-World Settings 2023 ·Viruses ·Cassidy Henegar, (unknown), Ruolan Wang, Charles B. Hicks, (unknown), (unknown), Annemiek de Ruiter, Vani Vannappagari	6
2	Immunogenicity of AGS-004 Dendritic Cell Therapy in Patients Treated During Acute HIV Infection 2017 ·AIDS Research and Human Retroviruses ·Cynthia L. Gay, Mark DeBenedette, Irina Y. Tcherepanova, (unknown), Whitney E. Lewis, Anna B. Cope, JoAnn Kuruc, Kara McGee, Mary F. Kearney, John M. Coffin, Nancie M. Archin, Charles B. Hicks, Joseph J. Eron, Charles A. Nicolette, David M. Margolis	50
3	Diagnosing HIV Infection in Primary Care Settings: Missed Opportunities 2013 ·AIDS Patient Care and STDs ·(unknown), Charles B. Hicks, Gregory P. Samsa, Mehri S. McKellar	48
4	Antiretroviral Therapy Initiated During Acute HIV Infection Fails to Prevent Persistent T-Cell Activation 2013 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Michael J. Vinikoor, Anna B. Cope, (unknown), Guido Ferrari, Kara McGee, (unknown), (unknown), David M. Margolis, Charles B. Hicks, (unknown)	42
5	Safety, Tolerability, and Efficacy of KP-1461 as Monotherapy for 124 Days in Antiretroviral-Experienced, HIV Type 1-Infected Subjects 2012 ·AIDS Research and Human Retroviruses ·Charles B. Hicks, Patrick G. Clay, Robert Redfield, Jay Lalezari, (unknown), Stefan Schneider, Michael Sension, MaryPeace McRae, Jean‐Pierre Laurent	13
6	Pre-Exposure Prophylaxis - One More Tool for HIV Prevention 2012 ·Current HIV Research ·Anna K. Person, Charles B. Hicks	16
7	Unmet therapeutic needs in the new era of combination antiretroviral therapy for HIV-1 2010 ·Journal of Antimicrobial Chemotherapy ·Babafemi Taiwo, Charles B. Hicks, Joe Eron	37
8	Syphilis and HIV: The Intersection of Two Epidemics 2010 ·Journal watch ·Becky A. Miller, Charles B. Hicks	4
9	Comparison of Once-Daily Fosamprenavir Boosted with Either 100 or 200 mg of Ritonavir, in Combination with Abacavir/Lamivudine: 96-Week Results from COL100758 2009 ·AIDS Research and Human Retroviruses ·Charles B. Hicks, Edwin DeJesus, Louis Sloan, Michael Sension, David A. Wohl, Qiming Liao, Lisa Ross, Gary E. Pakes, Keith A. Pappa, (unknown)	17
10	Heterogeneous neutralizing antibody and antibody-dependent cell cytotoxicity responses in HIV-1 elite controllers 2009 ·AIDS ·Olivier Lambotte, Guido Ferrari, Christiane Moog, Nicole L. Yates, Hua‐Xin Liao, Robert Parks, Charles B. Hicks, Kouros Owzar, Georgia D. Tomaras, David C. Montefiori, Barton F. Haynes, Jean‐François Delfraissy	260
11	Seven-Year Efficacy of a Lopinavir/Ritonavir-Based Regimen in Antiretroviral—Naïve HIV-1-Infected Patients 2008 ·HIV Clinical Trials ·Robert L. Murphy, Barbara A. da Silva, Charles B. Hicks, Joseph J. Eron, Roy M. Gulick, Melanie Thompson, (unknown), Martin King, George J. Hanna, Scott C. Brun	52
12	Low CD4-Cell Counts — Not Just About OI Risk 2008 ·Journal watch ·Charles B. Hicks	1
13	Human Immunodeficiency Virus Type 1 gp41 Antibodies That Mask Membrane Proximal Region Epitopes: Antibody Binding Kinetics, Induction, and Potential for Regulation in Acute Infection 2007 ·Journal of Virology ·S. Munir Alam, Richard M. Scearce, Robert Parks, (unknown), (unknown), Laura L. Sutherland, Miroslaw K. Górny, Susan Zolla‐Pazner, (unknown), M. Anthony Moody, Shi-Mao Xia, David C. Montefiori, Georgia D. Tomaras, Kent J. Weinhold, Salim S. Abdool Karim, Charles B. Hicks, Hua‐Xin Liao, James E. Robinson, George M. Shaw, Barton F. Haynes	85
14	Pooled 24-Week Results of DUET-1 and -2: Efficacy of TMC125 in Treatment-Experienced HIV-1-Infected Patients 2007 ·Charles B. Hicks	5
15	Late Diagnosis of HIV Infection: The Role of Age and Sex 2007 ·The American Journal of Medicine ·Michael J. Mugavero, (unknown), David Edelman, Charles B. Hicks	98
16	Detection of minor drug-resistant populations by parallel allele-specific sequencing 2007 ·Nature Methods ·Fangping Cai, Haifeng Chen, Charles B. Hicks, John Bartlett, Jun Zhu, Feng Gao	49
17	Report from the XVI International AIDS Conference. Integrase inhibitors. 2006 ·PubMed ·Charles B. Hicks	2
18	Current Management Challenges in HIV: Tolerability of Antiretrovirals and Metabolic Complications 2003 ·AIDS Patient Care and STDs ·Charles B. Hicks, Judith S. Currier, Paul E. Sax, Renslow Sherer, Christine Wanke	18
19	Failure of Benzathine Penicillin in a Case of Seronegative Secondary Syphilis in a Patient With Acquired Immunodeficiency Syndrome: Case Report and Review of the Literature 2001 ·Archives of Dermatology ·Vance G. Fowler, G. Larry Maxwell, Sarah A. Myers, Christopher R. Shea, (unknown), Víctor G. Prieto, Charles B. Hicks	16
20	Safety and immunogenicity of an HLA-based HIV envelope polyvalent synthetic peptide immunogen 1998 ·AIDS ·John Bartlett, Steven S. Wasserman, Charles B. Hicks, (unknown), Kent J. Weinhold, Carol O. Tacket, Nzeera Ketter, Alec E. Wittek, T J Palker, Barton F. Haynes	35

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact